Kintara Therapeutics Statistics
Total Valuation
KTRA has a market cap or net worth of $14.33 million. The enterprise value is $7.98 million.
Market Cap | 14.33M |
Enterprise Value | 7.98M |
Important Dates
The last earnings date was Tuesday, May 14, 2024, after market close.
Earnings Date | May 14, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
KTRA has 55.30 million shares outstanding. The number of shares has increased by 2,550.92% in one year.
Shares Outstanding | 55.30M |
Shares Change (YoY) | +2,550.92% |
Shares Change (QoQ) | +927.48% |
Owned by Insiders (%) | 0.13% |
Owned by Institutions (%) | 0.90% |
Float | 55.28M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.42 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.04, with zero debt.
Current Ratio | 5.04 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 102.42 |
Financial Efficiency
Return on equity (ROE) is -852.50% and return on invested capital (ROIC) is -158.98%.
Return on Equity (ROE) | -852.50% |
Return on Assets (ROA) | -257.30% |
Return on Capital (ROIC) | -158.98% |
Revenue Per Employee | n/a |
Profits Per Employee | -$4.76M |
Employee Count | 2 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -93.73% in the last 52 weeks. The beta is 0.70, so KTRA's price volatility has been lower than the market average.
Beta (5Y) | 0.70 |
52-Week Price Change | -93.73% |
50-Day Moving Average | 0.20 |
200-Day Moving Average | 0.79 |
Relative Strength Index (RSI) | 53.35 |
Average Volume (20 Days) | 12,417,397 |
Short Selling Information
The latest short interest is 1.43 million, so 2.58% of the outstanding shares have been sold short.
Short Interest | 1.43M |
Short Previous Month | 4.74M |
Short % of Shares Out | 2.58% |
Short % of Float | 2.58% |
Short Ratio (days to cover) | 0.08 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -9.42M |
Pretax Income | -9.33M |
Net Income | -9.51M |
EBITDA | -9.37M |
EBIT | -9.42M |
Earnings Per Share (EPS) | -$4.07 |
Balance Sheet
The company has $6.35 million in cash and no debt, giving a net cash position of $6.35 million or $0.11 per share.
Cash & Cash Equivalents | 6.35M |
Total Debt | n/a |
Net Cash | 6.35M |
Net Cash Per Share | $0.11 |
Equity (Book Value) | 5.92M |
Book Value Per Share | 0.11 |
Working Capital | 5.41M |
Cash Flow
In the last 12 months, operating cash flow was -$7.24 million and capital expenditures -$20,000, giving a free cash flow of -$7.26 million.
Operating Cash Flow | -7.24M |
Capital Expenditures | -20,000 |
Free Cash Flow | -7.26M |
FCF Per Share | -$0.16 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
KTRA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2,550.92% |
Shareholder Yield | -2,550.92% |
Earnings Yield | -66.38% |
FCF Yield | -50.68% |
Analyst Forecast
The average price target for KTRA is $14.00, which is 5,303.32% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $14.00 |
Price Target Difference | 5,303.32% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 14, 2022. It was a reverse split with a ratio of 1:50.
Last Split Date | Nov 14, 2022 |
Split Type | Reverse |
Split Ratio | 1:50 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |